United States · FDA National Drug Code directory
Risedronate Sodium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 60505-3165_03750616-5c88-729a-215e-3d796f8ba6a8
- Product NDC
- 60505-3165
- Form
- TABLET, FILM COATED
- Composition / generic term
- Risedronate Sodium
- Labeler
- Apotex Corp.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20151130
- Source listing expiry
- 20271231
Source-listed ingredients
- RISEDRONATE SODIUM — 35 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BLISTER PACK in 1 CARTON (60505-3165-0) / 4 TABLET, FILM COATED in 1 BLISTER PACK · 60505-3165-0
- 3 BLISTER PACK in 1 CARTON (60505-3165-2) / 4 TABLET, FILM COATED in 1 BLISTER PACK · 60505-3165-2
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →